PortfoliosLab logoPortfoliosLab logo
PSTV vs. TNYA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PSTV vs. TNYA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Plus Therapeutics Inc (PSTV) and Tenaya Therapeutics, Inc. (TNYA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PSTV achieves a -57.29% return, which is significantly lower than TNYA's 11.03% return.


PSTV

1D
-4.04%
1M
-10.18%
YTD
-57.29%
6M
-62.92%
1Y
-40.49%
3Y*
-61.82%
5Y*
-64.45%
10Y*
-67.91%

TNYA

1D
-9.20%
1M
11.93%
YTD
11.03%
6M
-35.25%
1Y
71.74%
3Y*
-53.06%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PSTV vs. TNYA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
PSTV
Plus Therapeutics Inc
-57.29%-55.45%-34.29%-63.19%-69.81%-44.74%
TNYA
Tenaya Therapeutics, Inc.
11.03%-50.24%-55.86%61.19%-89.39%23.45%

Correlation

The correlation between PSTV and TNYA is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Aug 2, 2021

0.17

Fundamentals

Market Cap

PSTV:

$36.35M

TNYA:

$171.34M

EPS

PSTV:

-$4.87

TNYA:

-$0.48

PS Ratio

PSTV:

3.23

TNYA:

610.93

PB Ratio

PSTV:

3.04

TNYA:

1.61

Total Revenue (TTM)

PSTV:

$4.15M

TNYA:

$225.00K

Gross Profit (TTM)

PSTV:

$3.89M

TNYA:

$0.00

EBITDA (TTM)

PSTV:

-$1.39M

TNYA:

-$78.62M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PSTV vs. TNYA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSTV
PSTV Risk / Return Rank: 3636
Overall Rank
PSTV Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
PSTV Sortino Ratio Rank: 4545
Sortino Ratio Rank
PSTV Omega Ratio Rank: 4444
Omega Ratio Rank
PSTV Calmar Ratio Rank: 3232
Calmar Ratio Rank
PSTV Martin Ratio Rank: 3232
Martin Ratio Rank

TNYA
TNYA Risk / Return Rank: 6262
Overall Rank
TNYA Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
TNYA Sortino Ratio Rank: 6969
Sortino Ratio Rank
TNYA Omega Ratio Rank: 6666
Omega Ratio Rank
TNYA Calmar Ratio Rank: 6060
Calmar Ratio Rank
TNYA Martin Ratio Rank: 5656
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSTV vs. TNYA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Plus Therapeutics Inc (PSTV) and Tenaya Therapeutics, Inc. (TNYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PSTVTNYADifference

Sharpe ratio

Return per unit of total volatility

-0.26

0.64

-0.90

Sortino ratio

Return per unit of downside risk

0.66

1.70

-1.04

Omega ratio

Gain probability vs. loss probability

1.08

1.21

-0.13

Calmar ratio

Return relative to maximum drawdown

-0.27

0.97

-1.25

Martin ratio

Return relative to average drawdown

-0.47

1.55

-2.02

PSTV vs. TNYA - Sharpe Ratio Comparison

The current PSTV Sharpe Ratio is -0.26, which is lower than the TNYA Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of PSTV and TNYA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PSTVTNYADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.26

0.64

-0.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.37

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.35

-0.42

+0.08

Drawdowns

PSTV vs. TNYA - Drawdown Comparison

The maximum PSTV drawdown since its inception was -100.00%, roughly equal to the maximum TNYA drawdown of -98.69%. Use the drawdown chart below to compare losses from any high point for PSTV and TNYA.


Loading charts...

Drawdown Indicators


PSTVTNYADifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-98.69%

-1.31%

Max Drawdown (1Y)

Largest decline over 1 year

-86.87%

-73.81%

-13.06%

Max Drawdown (3Y)

Largest decline over 3 years

-97.03%

-94.92%

-2.11%

Max Drawdown (5Y)

Largest decline over 5 years

-99.73%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

Current Drawdown

Current decline from peak

-100.00%

-97.33%

-2.67%

Average Drawdown

Average peak-to-trough decline

-79.49%

-82.08%

+2.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.75%

46.25%

+4.50%

Volatility

PSTV vs. TNYA - Volatility Comparison

The current volatility for Plus Therapeutics Inc (PSTV) is 23.89%, while Tenaya Therapeutics, Inc. (TNYA) has a volatility of 29.89%. This indicates that PSTV experiences smaller price fluctuations and is considered to be less risky than TNYA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PSTVTNYADifference

Volatility (1M)

Calculated over the trailing 1-month period

23.89%

29.89%

-6.00%

Volatility (6M)

Calculated over the trailing 6-month period

88.49%

86.15%

+2.34%

Volatility (1Y)

Calculated over the trailing 1-year period

157.00%

113.37%

+43.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

198.00%

109.13%

+88.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

184.24%

109.13%

+75.11%

Dividends

PSTV vs. TNYA - Dividend Comparison

Neither PSTV nor TNYA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PSTV vs. TNYA - Financials Comparison

This section allows you to compare key financial metrics between Plus Therapeutics Inc and Tenaya Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00K1.00M1.50M2.00M202220232024202520260
225.00K
(PSTV) Total Revenue
(TNYA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PSTV and TNYA have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TNYA has higher volatility (29.89%) compared to PSTV (23.89%). In terms of maximum drawdown, PSTV dropped -100.00% vs TNYA's -98.69%.

TNYA currently has the higher Sharpe Ratio (0.64 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PSTV and TNYA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer